<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72048">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01726842</url>
  </required_header>
  <id_info>
    <org_study_id>rebiscan-001</org_study_id>
    <nct_id>NCT01726842</nct_id>
  </id_info>
  <brief_title>Amblyopia and Strabismus Detection Using a Pediatric Vision Scanner</brief_title>
  <official_title>Pediatric Vision Scanner for the Eradication of Amblyopia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rebiscan, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Retina Foundation of the Southwest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rebiscan, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to compare the performance of the Pediatric Vision Scanner
      (PVS) with the Gold Standard Examination to determine the effectiveness of the PVS at
      detecting amblyopia and strabismus.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Binocularity score</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of amblyopia risk factors</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Amblyopia</condition>
  <condition>Strabismus</condition>
  <arm_group>
    <arm_group_label>Normal Controls</arm_group_label>
    <description>Structurally normal eye with equal visual acuity and normal stereopsis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Referral required</arm_group_label>
    <description>Diagnosed with amblyopia or constant strabismus, categorized based on the GSE.
Amblyopia:
VA &lt;20/40 and 2 logMAR lines difference in normal eye
Mild amblyopia (&gt;20/40)
Moderate amblyopia (20/40 and &lt;20/100)
Severe amblyopia (≥20/100 or worse)
Bilateral amblyopia: &gt;4 years age VA&lt;20/40 OU including high hyperopia or high astigmatism.
Strabismus:
Constant: &gt;2 PD at near and or distance.
Intermittent: strabismus that could be controlled intermittently either through fusional mechanisms or a compensatory head position.
Amblyogenic factor categorization:
'Anisometropia'- (1.5 Diopters (D) or more difference in refractive error between the two eyes.
'hypermetropia' (≥3.5 D),
'myopia' (≥-4.0 D),
'astigmatism' (≥1.5 D).
'structural abnormalities' of the eye will not be excluded, but will be considered to have vision loss if visual acuity is 20/40 or worse.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Borderline</arm_group_label>
    <description>(no long-term harm to patient if referral is delayed, however the patient does have conditions that might benefit from monitoring): Equal visual acuity and no structural abnormality with any of the following: Amblyogenic factor, intermittent strabismus, structural abnormalities, refractive error, reduced stereopsis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pediatric Vision Scanner</intervention_name>
    <description>Subject is scanned with a 2.5 second pediatric vision scanner device test.</description>
    <arm_group_label>Normal Controls</arm_group_label>
    <arm_group_label>Referral required</arm_group_label>
    <arm_group_label>Borderline</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children presenting for ophthalmic exam at eye clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion:

          -  2-6 years old

          -  complete ophthalmic examination including cycloplegic refraction conducted on the
             same day or within 3 months

          -  strabismic, anisometropic, or normal (normal eye examination and refractive error
             according to AAPOS guidelines)

          -  parent provides informed consent

        Exclusion:

          -  other ocular disease (includes media opacities, anomalous optic nerve, ptosis, lid
             hemangioma, conjunctivitis, blepharitis, symptomatic NLD) or systemic disease (JIA,
             JRA, neurofibromatosis)

          -  developmental delay

          -  strabismus surgery in the past 6 months
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eileen Birch, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Retina Foundation of the Southwest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Retina Foundation of the Southwest</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Loudon SE, Rook CA, Nassif DS, Piskun NV, Hunter DG. Rapid, high-accuracy detection of strabismus and amblyopia using the pediatric vision scanner. Invest Ophthalmol Vis Sci. 2011 Jul 7;52(8):5043-8. doi: 10.1167/iovs.11-7503.</citation>
    <PMID>21642624</PMID>
  </reference>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 11, 2012</lastchanged_date>
  <firstreceived_date>October 5, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amblyopia</mesh_term>
    <mesh_term>Strabismus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
